Answers are grounded in this paper and cite their sources.
Cutaneous T-cell lymphoma (CTCL) represents a diagnostic challenge because of its large symptomatic overlap with other common skin conditions such as atopic dermatitis (AD) and psoriasis. Dupilumab has offered promising results in AD treatment; however, concerns exist that its use may exacerbate undiagnosed CTCL. We present a patient with CTCL and concomitant AD who experienced improvement in both CTCL blood involvement and AD following the addition of dupilumab therapy.
No takes yet. Share an insight, caveat, or question.
Mollanazar et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: